Stocks
Applied Molecular Transport Financial Statements (AMTI) |
||||||||||
| Applied Molecular Transportsmart-lab.ru | % | 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 31.12.2018 | 31.12.2019 | 19.03.2021 | 24.02.2022 | 09.03.2023 | 09.11.2023 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||
| Operating Income, bln rub | -29.9 | -28.3 | -66.7 | -100.8 | -127.2 | -76.5 | ||||
| EBITDA, bln rub | ? | -29.2 | -27.6 | -66.7 | -100.8 | -127.2 | -42.8 | |||
| Net profit, bln rub | ? | -29.9 | -28.0 | -64.5 | -96.4 | -125.4 | -73.1 | |||
| OCF, bln rub | ? | -27.5 | -27.0 | -58.9 | -82.6 | -93.9 | -60.0 | |||
| CAPEX, bln rub | ? | 0.545 | 2.15 | 5.32 | 1.86 | 4.15 | 0.452 | |||
| FCF, bln rub | ? | -28.0 | -29.1 | -64.2 | -84.5 | -98.1 | -60.5 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | ||||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 29.9 | 28.3 | 66.7 | 100.8 | 127.2 | 59.7 | ||||
| Cost of production, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| R&D, bln rub | 27.9 | 24.3 | 53.9 | 71.4 | 89.8 | 30.2 | ||||
| Interest expenses, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.579 | ||||
| Assets, bln rub | 23.2 | 38.5 | 140.2 | 214.0 | 107.4 | 20.0 | ||||
| Net Assets, bln rub | ? | -44.1 | -71.7 | 131.7 | 163.6 | 60.8 | 16.2 | |||
| Debt, bln rub | 0.000 | 0.000 | 0.636 | 39.8 | 36.1 | 1.35 | ||||
| Cash, bln rub | 20.3 | 32.4 | 129.9 | 159.8 | 61.1 | 18.1 | ||||
| Net debt, bln rub | -20.3 | -32.4 | -129.2 | -120.0 | -25.0 | -16.8 | ||||
| Ordinary share price, rub | 30.8 | 14.0 | 0.420 | 0.140 | ||||||
| Number of ordinary shares, mln | 17.6 | 21.4 | 22.9 | 37.6 | 38.8 | 39.8 | ||||
| Market cap, bln rub | 0 | 0 | 704 | 526 | 16 | 6 | ||||
| EV, bln rub | ? | -20 | -32 | 575 | 405 | -9 | -11 | |||
| Book value, bln rub | -44 | -72 | 132 | 164 | 61 | 16 | ||||
| EPS, rub | ? | -1.70 | -1.31 | -2.82 | -2.56 | -3.23 | -1.84 | |||
| FCF/share, rub | -1.59 | -1.36 | -2.81 | -2.25 | -2.52 | -1.52 | ||||
| BV/share, rub | -2.51 | -3.35 | 5.76 | 4.35 | 1.57 | 0.41 | ||||
| FCF yield, % | ? | -9.12% | -16.1% | -601.1% | -1 087% | |||||
| ROE, % | ? | 67.7% | 39.1% | -49.0% | -58.9% | -206.2% | -450.4% | |||
| ROA, % | ? | -128.5% | -72.8% | -46.0% | -45.0% | -116.7% | -365.5% | |||
| P/E | ? | 0.00 | 0.00 | -10.9 | -5.45 | -0.13 | -0.08 | |||
| P/FCF | 0.00 | 0.00 | -11.0 | -6.22 | -0.17 | -0.09 | ||||
| P/BV | ? | 0.00 | 0.00 | 5.35 | 3.21 | 0.27 | 0.34 | |||
| EV/EBITDA | ? | 0.69 | 1.17 | -8.62 | -4.02 | 0.07 | 0.26 | |||
| Debt/EBITDA | 0.69 | 1.17 | 1.94 | 1.19 | 0.20 | 0.39 | ||||
| R&D/CAPEX, % | 5 125% | 1 129% | 1 015% | 3 833% | 2 163% | 6 689% | ||||
| Applied Molecular Transport shareholders | ||||||||||
